Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STERO-AHF corticosteroids in diuretic-resistant acute heart failure
2022-003206-69Phase 2Terminated
- Sponsor
- ASST Spedali Civili di Brescia
- Start
- Nov 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dexamethasone and prednisone in Acute Heart Failure (AHF) (2 arms), sponsored by ASST Spedali Civili di Brescia. Primary endpoint: Primary: diuretic response. Started Nov 2022; status: terminated.
02
Drugs
dexamethasoneprednisone
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on 2022-003206-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003206-69.